| pubmed-article:18629630 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C0041538 | lld:lifeskim |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C0077678 | lld:lifeskim |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C0013081 | lld:lifeskim |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C0279025 | lld:lifeskim |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C1420046 | lld:lifeskim |
| pubmed-article:18629630 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
| pubmed-article:18629630 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:18629630 | pubmed:dateCreated | 2009-6-15 | lld:pubmed |
| pubmed-article:18629630 | pubmed:abstractText | In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line tamoxifen therapy. The aim of this study was to evaluate SIAH2 for its (a) predictive/prognostic value, and (b) functional role in endocrine therapy resistance. | lld:pubmed |
| pubmed-article:18629630 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18629630 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18629630 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18629630 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18629630 | pubmed:issn | 1573-7217 | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:LookMaxime... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:Meijer-van... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:KlijnJan G... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:FoekensJohn... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:BernsEls M... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:SieuwertsAnie... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:DorssersLambe... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:HellemanJozie... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:SleijferStefa... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:JansenMaurice... | lld:pubmed |
| pubmed-article:18629630 | pubmed:author | pubmed-author:Ruigrok-Ritst... | lld:pubmed |
| pubmed-article:18629630 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18629630 | pubmed:volume | 116 | lld:pubmed |
| pubmed-article:18629630 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18629630 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18629630 | pubmed:pagination | 263-71 | lld:pubmed |
| pubmed-article:18629630 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:meshHeading | pubmed-meshheading:18629630... | lld:pubmed |
| pubmed-article:18629630 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18629630 | pubmed:articleTitle | Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer. | lld:pubmed |
| pubmed-article:18629630 | pubmed:affiliation | Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute, Rotterdam, The Netherlands. m.p.h.m.jansen@erasmusmc.nl | lld:pubmed |
| pubmed-article:18629630 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18629630 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:6478 | entrezgene:pubmed | pubmed-article:18629630 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18629630 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18629630 | lld:pubmed |
